References
- Warrell R P, Jr, de The H, Wang Z Y, Degos L. Acute promyelocytic leukemia. N Eng J Med 1993; 329: 177–189
- Melick A, Licht J D. Deconstructing a disease: RAR alpha, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167–3215
- He L Z, Tribioli C, Rivi R, Peruzzi D, Pelicci P G, Soares V, et al. Acute leukemia with promyelocytic features in PML/RAR alpha transgenic mice. Proc Natl Acad Sci USA 1997; 94: 5302–5307
- He L, Bhaumik M, Tribioli C, Rego E M, Ivins S, Zelent A, et al. Two critical hits for promyelocytic leukemia. Mol Cell 2000; 6: 1131–1141
- Fukutani H, Naoe T, Yoshida H, Yamamori S, Ohno R. Molecular heterogeneity of the PML gene rearrangement in acute promyelocytic leukemia: prevalence and clinical significance. Jpn J Cancer Res 1993; 84: 257–264
- Huang W, Sun G L, Li X S, Cao Q, Lu Y, Jang G S, et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264–1269
- Pandolfi P P, Alcalay M, Faqioli M, Zangrill D, Mencarelli A, Diverio D, et al. Geomic variability and alternative splicing generate multiple AML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemia. EMBO J 1992; 11: 1397–1407
- Pandolfi P P. Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum Mol Gen 2001; 10: 769–775
- Dyck J A, Maul G G, Miller W H, Jr, Chen J D, Kakizuka A, Evans R M. A noel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333–343
- Zimonjic D B, Pollock J L, Westervelt P, Popescu N C, Ley T J. Acquired nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc Natl Acad Sci USA 2000; 97: 13306–13311
- Wang Z G, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R, et al. PML is essential for multiple apoptotic pathways. Nat Genet 1998; 20: 266–272
- Lai H K, Borden K L. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA. Oncogene 2000; 19: 1623–1634
- Wang Z G, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, et al. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547–1551
- Seabright M A. A rapid banding technique for human chromosomes. Lancet 1971; 971–972
- Chillόn M C, Gonzalez M, Garcia-Sanz R, Balanzategui A, Gonzalez D, Lopez-Perez R, et al. Two new 3′ PML breakpoints in t(15;17) (q22;21q)—positive acute promyelocytic leukemia. Genes Chromosomes Cancer 2000; 27: 35–43
- Robertson K A, Emami B, Collins J. Retinoic acid-resistant HL-60R cells harbour a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 1992; 80: 1885–1889
- Strudwick S, Borden K LB. Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities. Leukemia 2002; 16: 1906–1917
- Lufkin T, Lohnes D, Mark M, Dierich A, Gorvy P, Gaub M P, et al. High postnatal lethality and tests degeneration in retinoic receptor alpha mutant mice. Proc Natl Acad Sci USA 1993; 90: 7225–7229
- Kuwata T, Wang I M, Tamura T, Ponnamperuma R M, Levine R, Holmes K L, et al. Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood 2000; 95: 3349–3356
- Liu T X, Zhang J W, Tao J, Zhang R B, Zhang Q H, Zhao C J, et al. Gene expression networks underlying retinoic acid-induced differentiation acute promyelocytic leukemia cells. Blood 2000; 96: 1496–1504